your market intelligence analyst
Search Results
7 results
Your search is now limited to «Biomarkers» expert search.
Healio News 02/19/2020 14:18
Initiating Alzheimer’s disease treatment before amyloid-beta levels become pathological provides patients with significant benefit, according to study findings published in Biological Psychiatry. Researchers noted that noninvasive, low-cost cognitive measures may help determine patients at risk for progressing to amyloid-beta positivity. “There have been massive advances in Alzheimer’s disease biomarkers that have been critical to improving our understanding and study of the disease,” Jeremy A. Elman, PhD, of the department of psychiatry at University of California, San.
Business Wire 02/18/2020 07:00
GERMANTOWN, Maryland--(BUSINESS WIRE)--Precision Molecular, Inc. (PMI), a clinical-stage company with the mission to develop imaging biomarkers and theranostics, today announced that the Alzheimer’s Drug Discovery Foundation (ADDF) made an investment in the company to support advancement of more effective ways to image neuroinflammation, with a view to discovery of early imaging biomarkers for Alzheimer’s disease.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities


Strategic Scenarios